Dr Brunn has a doctorate in chemistry and, since 2001, has been president of Takeda Pharma, a wholly owned subsidiary of Takeda in Germany. He previously worked at Upjohn, Pharmacia & Upjohn and Pharmacia in various functions.
Yasuchika Hasegawa, president of Takeda, said: “Dr Brunn has a proven track record of success and excellence, which is apparent through the remarkable growth achieved by Takeda Pharma under his leadership. We are confident that he will provide Takeda Pharmaceuticals Europe (TPEU) with the same level of success as he takes on this pivotal role as CEO of TPEU.”